Medicamen Organics Limited (NSE:MEDIORG)

India flag India · Delayed Price · Currency is INR
29.25
-0.80 (-2.66%)
Apr 29, 2026, 3:25 PM IST
-0.68%
Market Cap 342.23M
Revenue (ttm) 394.30M
Net Income (ttm) 45.74M
Shares Out 11.70M
EPS (ttm) 3.84
PE Ratio 7.62
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,000
Average Volume 27,200
Open 29.25
Previous Close 30.05
Day's Range 29.25 - 29.25
52-Week Range 20.05 - 49.70
Beta n/a
RSI 59.07
Earnings Date May 29, 2026

About Medicamen Organics

Medicamen Organics Limited develops, manufactures, and distributes a range of pharmaceutical dosage. The company offers anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental cure, proton pump inhibitor, anti-protozoal, anti-histamine, anti-hypertensive, anti-lipidemic, anti-parasitic, multivitamin, multimineral, and non-steroidal anti-inflammatory drugs in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. It also provides skincare, haircare, and cosmetic products unde... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1995
Employees 114
Stock Exchange National Stock Exchange of India
Ticker Symbol MEDIORG
Full Company Profile

Financial Performance

In fiscal year 2025, Medicamen Organics's revenue was 381.88 million, an increase of 51.11% compared to the previous year's 252.72 million. Earnings were 40.47 million, an increase of 54.22%.

Financial Statements

News

There is no news available yet.